SPRY Operating Cash Flow Growth
Ars Pharmaceuticals Inc · Operating Cash Flow Growth
SPRY Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-272.00%period ending
SPRY TTM Cash from Operations YoY % (-37.85% → -272.00%)
Year-over-year change
High-resolution chart · PNG
SPRY operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -272.0003% | |
| -754.6671% | |
| -1,361.1898% | |
| -86.1647% | |
| -19.5665% | |
| 61.7458% | |
| 122.8596% | |
| 26.4553% | |
| 20.1169% | |
| -17.474% | |
| -47.8766% | |
| -52.5168% | |
| -1.7562% | |
| 25.8636% | |
| 39.967% | |
| 19.6707% | |
| -37.8511% |